Life Technologies reported $-19530000 in Net Income for its fiscal quarter ending in June of 2025.


Net Income Change Date
Ardelyx USD -19080000 23.72M Jun/2025
Biogen USD 634.8M 394.3M Jun/2025
Bristol-Myers Squibb USD 1.31B 1.15B Jun/2025
Cipla INR 12.98B 757.8M Jun/2025
Clal Biotechnology ILS -6166000 15.56M Dec/2022
Compugen USD -7340000 1.22M Jun/2025
CSL USD 2.01B 1.27B Dec/2024
Galapagos EUR -105748000 47.66M Jun/2025
GlaxoSmithKline GBP 1.44B 181M Jun/2025
Grifols EUR 68.97M 17.28M Dec/2024
Life Technologies USD -19530000 4.56M Jun/2025
Novartis USD 4.02B 418M Jun/2025
Roche Holding CHF 1.01B 2.12B Dec/2024
United Therapeutics USD 309.5M 12.7M Jun/2025